Urinalysis Test Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Urinalysis Test Market Test Type (Sediment, Biochemical,  Flow-Cytometric, Microscopic), By Product Type ( Reagent, Dipstick,  POC, Analyzers), Application ( UTI, Diabetes,  Liver Disease, Kidney, Pregnancy), End User (Hospitals, Diagnostic Labs, Others) By Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Urinalysis Test Market size was valued at USD 3.6 billion in 2021. It is expected to reach a value of USD 5.0 billion by 2028, growing at a CAGR of 7.3%. during 2022-2028. Urinalysis is an investigation of urine. The urinalysis test incorporates different investigation for conclusion of some normal malady, for example, urinary tract contaminations, kidney issue, diabetes, and liver issues. In such restorative conditions, urinalysis testing includes synthetic, visual, and minuscule examinations to identify cell pieces and substances, for example, gems or throws in the pee. This test is presumably utilized for the location of diabetes as pervasiveness of diabetic cases is rising step by step. The urinalysis test market is exceedingly divided and depends on new item dispatches and clinical consequences of items. Henceforth the real players have utilized different procedures, for example, new item dispatches, clinical preliminaries, showcase activities, high cost on innovative work, understandings, joint endeavors, organizations, acquisitions, and others to build their impressions in this market. Market members are always occupied with the presentation of novel demonstrative items trying to guarantee their supportability and increment the entrance of their item portfolio.

 

The Urinalysis Test Market Key Developments:

In June 2014, Roche propelled a completely robotized pee testing analyzer named Cobas 6500 with a goal to improve staff wellbeing and increment the outcome dependability.

 

Urinalysis Test Market

MARKET SUMMARY
-
7.3%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 7.3%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Urinalysis Test Market

  • Urinalysis Test Market gives historical, current, and future market sizes (US$ Bn) of product type and distribution channel and geographic regions.
  • This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
  • In addition, the market report includes regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.
  • Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
  • Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of Infant nutrition
Market Key Players
  • Hoffmann-La Roche Ltd (Switzerland)
  • Dahaner (U.S.)
  • Bio-Rad Laboratories, Inc.  (U.S.)
  • ARKRAY, Inc. (Japan)
  • Siemens AG (U.S.)
  • ACON Laboratories Inc. (U.S.)
  • Sysmex Corporation (Japan)
Growth

Urinalysis Test Market

Factors such as growing demand for point-of-care testing, enhance in global geriatric population, new advancement in technology innovation of urinalysis propel the market growth of urinalysis test. Moreover, growth in healthcare expenditure, development of basic medical insurance system in the near future boost the growth of market. However, factors like lack of laboratory staff, High cost associated with advanced urine analyzers, acceptance of fully automated urine analyzers in growing economies is lower and stringent regulatory framework may hamper the growth of the market.


North-America Got Significant Share

Urinalysis Test Market

Geographically Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America overwhelmed the general urinalysis test market. The presentation of cutting-edge urinalysis test by entering market players in the U.S., positive government activities guaranteeing the advancement of human services testing, and the high measure of medicinal services spending in this locale are the key components crediting to the biggest piece of the pie of this region. Asia Pacific is relied upon to develop at the most noteworthy CAGR amid the forecast period. Development in this fragment is driven by the components, for example, rising interest for urinalysis test products, expanding medicinal services use, rising pervasiveness of diabetes, and developing geriatric populace are driving the development of the urinalysis test market in this locale.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Urinalysis Test Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Hoffmann-La Roche Ltd (Switzerland)
  • Dahaner (U.S.)
  • Bio-Rad Laboratories, Inc.  (U.S.)
  • ARKRAY, Inc. (Japan)
  • Siemens AG (U.S.)
  • ACON Laboratories Inc. (U.S.)
  • Sysmex Corporation (Japan)

Description

Urinalysis Test Market size was valued at USD 3.6 billion in 2021. It is expected to reach a value of USD 5.0 billion by 2028, growing at a CAGR of 7.3%. during 2022-2028. Urinalysis is an investigation of urine. The urinalysis test incorporates different investigation for conclusion of some normal malady, for example, urinary tract contaminations, kidney issue, diabetes, and liver issues. In such restorative conditions, urinalysis testing includes synthetic, visual, and minuscule examinations to identify cell pieces and substances, for example, gems or throws in the pee. This test is presumably utilized for the location of diabetes as pervasiveness of diabetic cases is rising step by step. The urinalysis test market is exceedingly divided and depends on new item dispatches and clinical consequences of items. Henceforth the real players have utilized different procedures, for example, new item dispatches, clinical preliminaries, showcase activities, high cost on innovative work, understandings, joint endeavors, organizations, acquisitions, and others to build their impressions in this market. Market members are always occupied with the presentation of novel demonstrative items trying to guarantee their supportability and increment the entrance of their item portfolio.

 

The Urinalysis Test Market Key Developments:

In June 2014, Roche propelled a completely robotized pee testing analyzer named Cobas 6500 with a goal to improve staff wellbeing and increment the outcome dependability.

 

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX